SIGNA 7.0T
GE Medical Systems, LLC • Radiology • 05/13/2021
Device Purpose
The SIGNA 7.0T is a high-field magnetic resonance imaging system designed for diagnostic imaging of the head and extremities, now incorporating the AIR Recon DL software feature to enhance image quality. This feature utilizes deep learning-based reconstruction to improve signal-to-noise ratio and image sharpness, as validated by non-clinical and clinical studies showing superior image characteristics and radiologist preference.
Summary
The SIGNA 7.0T is a whole-body magnetic resonance scanner operating at a 7.0 Tesla field strength, designed to produce high-resolution images for diagnostic purposes. It supports various imaging techniques including axial, sagittal, coronal, and oblique views, as well as spectroscopic images, parametric maps, and dynamic images of the head and extremities. The system utilizes a superconducting magnet and an ultra-high performance gradient coil within a 60 cm patient bore. The images generated reflect the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance, providing information that, when interpreted by a trained physician, can assist in diagnosis for patients weighing over 20 kg (44 lb). This particular iteration of the SIGNA 7.0T introduces the AIR Recon DL software feature and includes upgrades for installed base magnet systems. AIR Recon DL is a deep learning-based image reconstruction technology intended to improve image quality by increasing signal-to-noise ratio (SNR) and image sharpness while reducing image noise. Non-clinical performance testing demonstrated these improvements, showing that AIR Recon DL can maintain image SNR and sharpness even with reduced scan times, without adversely affecting low contrast detectability. Clinical evaluations, including a reader study with radiologists, confirmed that AIR Recon DL provides images with better SNR and equivalent or superior sharpness, leading to a uniform preference for these images in clinical assessment.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the AIR Recon DL algorithm differentiate between true anatomical signal and noise, particularly for subtle pathologies in high-resolution 7.0T imaging?; What is the quantifiable reduction in scan time achievable with AIR Recon DL on the SIGNA 7.0T while maintaining or improving diagnostic image quality compared to conventional reconstruction methods?; Are there specific contraindications or patient populations (e.g., those with certain implants compatible at 7T but perhaps interacting differently with the DL reconstruction) for whom the AIR Recon DL feature might be less suitable or require specific parameter adjustments?; How does the performance of AIR Recon DL on the SIGNA 7.0T compare to its previously cleared implementation on 3T systems, considering the differences in field strength, SNR characteristics, and potential artifacts?; What training data was used for the AIR Recon DL model specific to 7.0T imaging, and how does it account for the unique image contrasts and artifacts encountered at ultra-high field strengths?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly